Racura Oncology LtdASX: RAC

CPACS Trial Cleared to Escalate to Next RC220 Dose Level

May 15, 2026 at 3:24 AM UTC · Issued by Racura Oncology Ltd

Racura Oncology Ltd has released a press release.

View Attachment

Earlier from Racura Oncology

(E,E)-bisantrene Discovered to Function via Silencing of c-MYC ExpressionMay 6

All Racura Oncology news releases